This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Consiglio Nazionale Delle Ricerche. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Massimo Luigi Capobianco: Innovator in Oligonucleotide Research
Introduction
Massimo Luigi Capobianco is a notable inventor based in Bologna, Italy. He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide-based therapies. His work has implications for cancer treatment and other medical applications.
Latest Patents
Massimo holds a patent for "Oligonucleotide-anthracycline and oligonucleotide-anthracyclinone." This innovation showcases his expertise in combining oligonucleotides with anthracycline compounds, which are widely used in chemotherapy.
Career Highlights
He is affiliated with the Consiglio Nazionale delle Ricerche, a prominent research institution in Italy. His role there has allowed him to engage in cutting-edge research and development in the field of molecular biology.
Collaborations
Massimo has collaborated with esteemed colleagues such as Anna Maria Garbesi and Stefania Bonazzi. These partnerships have enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Massimo Luigi Capobianco's contributions to oligonucleotide research highlight his innovative spirit and dedication to advancing medical science. His patent and collaborations reflect his commitment to improving therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile